Search

Your search keyword '"Adcock I"' showing total 601 results

Search Constraints

Start Over You searched for: Author "Adcock I" Remove constraint Author: "Adcock I"
601 results on '"Adcock I"'

Search Results

1. Erratum to: Building bridges for innovation in ageing: Synergies between action groups of the EIP on AHA

2. Metabolic pathways in immune senescence and inflammaging: Novel therapeutic strategy for chronic inflammatory lung diseases. An EAACI position paper from the Task Force for Immunopharmacology

3. Metabolic pathways in immune senescence and inflammaging: Novel therapeutic strategy for chronic inflammatory lung diseases. An EAACI position paper from the Task Force for Immunopharmacology

4. Metabolic pathways in immune senescence and inflammaging: Novel therapeutic strategy for chronic inflammatory lung diseases. An EAACI position paper from the Task Force for Immunopharmacology

5. Metabolic pathways in immune senescence and inflammaging: Novel therapeutic strategy for chronic inflammatory lung diseases. An EAACI position paper from the Task Force for Immunopharmacology

6. Metabolic pathways in immune senescence and inflammaging: Novel therapeutic strategy for chronic inflammatory lung diseases. An EAACI position paper from the Task Force for Immunopharmacology.

7. Macrophage migration inhibitory factor promotes glucocorticoid resistance of neutrophilic inflammation in a murine model of severe asthma.

10. Building bridges for innovation in ageing: Synergies between action groups of the EIP on AHA

15. Identification of oropharyngeal microbiome-driven asthma and wheezing clusters in children

16. Sputum metagenomics of U-BIOPRED asthma cohort: link to severity and granulocytic inflammation

18. Bone Morphogenic Proteins and their antagonists in the lower airways of stable COPD patients

19. Radiomics for severe asthma phenotyping and endotyping

21. The regulation of IL33 following smoking cessation

26. Trends in prevalence, mortality, and disability-adjusted life-years relating to Chronic Obstructive Pulmonary Disease in Europe: 2001-2019

27. Relationship between interleukin-13 and transferrin receptor-1 responses in asthma pathogenesis

28. Is diet partly responsible for differences in COVID-19 death rates between and within countries?

30. Plasma proteins elevated in severe asthma despite oral steroid use and unrelated to Type-2 inflammation

31. Decreased serum levels of angiotensin converting enzyme (ACE)2 and enhanced cytokine levels with severity of COVID-19: normalisation upon disease recovery

33. Management of severe asthma: a European Respiratory Society/American Thoracic Society guideline

34. COVID-2019: Molecular and cellular response

36. Immune modulation via T regulatory cell enhancement: disease-modifying therapies for autoimmunity and their potential for chronic allergic and inflammatory diseases - An EAACI position paper of the Task Force on Immunopharmacology (TIPCO)

37. Immune modulation via T regulatory cell enhancement: disease-modifying therapies for autoimmunity and their potential for chronic allergic and inflammatory diseases - An EAACI position paper of the Task Force on Immunopharmacology (TIPCO)

39. Immune modulation via T regulatory cell enhancement: disease-modifying therapies for autoimmunity and their potential for chronic allergic and inflammatory diseases - An EAACI position paper of the Task Force on Immunopharmacology (TIPCO)

40. Circulating Levels of Monocytic Myeloid-Derived Suppressor Cells (M-MDSC) and CXCL-8 in Non-Small Cell Lung Cancer (NSCLC)

41. Increased complement component 5A signalling drives severe asthma pathogenesis

42. Correction to: Is diet partly responsible for differences in COVID-19 death rates between and within countries? (Clinical and Translational Allergy, (2020), 10, 1, (16), 10.1186/s13601-020-00323-0)

43. Correction to: Is diet partly responsible for differences in COVID-19 death rates between and within countries? (Clinical and Translational Allergy, (2020), 10, 1, (16), 10.1186/s13601-020-00323-0)

44. Sputum macrophage diversity and activation in asthma: role of severity and inflammatory phenotype

47. TLR7 promotes smoke-induced lung damage through the activity of mast cell tryptase

48. Characteristics and treatment regimens across ERS SHARP severe asthma registries

Catalog

Books, media, physical & digital resources